We would like to thank Congresswoman Doris Matsui and Congressman Buddy Carter, along with 18 other House colleagues, for their letter to DEA Administrator Anne Milgram, urging the DEA to extend the current flexibilities for telemedicine prescribing of controlled substances.

Thanks to the efforts of Congress and the telehealth community, the Office of Management and Budget (OMB) is currently reviewing a third extension titled “Third Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications.” This extension would allow waivers to remain in effect until December 31, 2025.

While this is not yet final, it signals that we are moving in the right direction. We will keep you updated as soon as the waiver is finalized.

Click here to read the full text of the letter to Administrator Milgram.

CTeL's RPM Summit

Friday, November 1 | 12-3 PM ET

Join CTeL's RPM Summit on Friday, November 1, at 12:00 PM ET, a premier virtual event dedicated to the latest advancements in remote patient monitoring, telehealth, and AI. This event is tailored for health professionals eager to stay ahead in the rapidly evolving digital health industry. Don’t miss this opportunity to gain critical insights and network with leading experts. Register Today!

CTeL's Fall 2024 Digital Health Summit

December 9-10, 2024 | Capitol Hill

Join CTeL's Fall 2024 Digital Health Summit on Capitol Hill, December 9-10, a premier event dedicated to the latest advancements in digital health, telehealth, and AI. This summit is tailored for health professionals, attorneys and associates eager to stay ahead in the rapidly evolving digital health industry. Don’t miss this opportunity to gain critical insights and network with leading experts. Register Today!